Терапевтическая тактика при третичном гиперпаратиреозе после трансплантации почки (Обзор литературы и клинические наблюдения)


О.Н. Ветчинникова, Р.О. Кантария

ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»
Представлены обзор литературы и собственный опыт лечения больных гиперпаратиреозом после трансплантации почки. Рассмотрены особенности клинических проявлений, минерально-костных нарушений, диагностический алгоритм и способы лечения третичного гиперпаратиреоза: хирургические методы и фармакотерапия с применением цинакалцета.

Литература



  1. Kinnaert P., Nagy N., Decoster-Gervy C. Persistent Hyperparathyroidism Requiring Surgical Treatment after Kidney Transplantation // World J Surg. – 2000. – Vol. 24. – P. 1391–1395.

  2. Evenepoel P., Claes K., Kuypers D. Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study // Nephrol Dial Transplant. – 2004. – Vol. 19. – P. 1281–1287.

  3. Kawarazaki H., Shibagaki Y., Fukumoto S. Natural History of Mineral and Bone Disorders After Living-Donor Kidney Transplantation: A One-Year Prospective Observational Study // Ther Apher Dial. – 2011. – Vol. 15(5). – P. 481–487.

  4. Bleskestad I.H., Bergrem H., Leivestad T. et al. Intact parathyroid hormone levels in renal transplant patients with normal transplant function // Clin Transplant. – 2011. – Vol. 25. – P. E566–E570.

  5. Dumoulin G., Hory B., Nguyen N.U. No trend towards a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients // Am J Kidney Dis. – 1997. – Vol. 29. – P. 746–753.

  6. Torres A., Rodriguez A.P., Concepcion M.T. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations // Nephrol Dial Transplant. – 1998. – Vol. 13 [Suppl 3]. – P. 94–97.

  7. Borchhardt K.A., Diarra D., Sulzbacher I. Cinacalcet Decreases Bone Formation Rate in Hypercalcemic Hyperparathyroidism after Kidney Transplantation // Am J Nephrol. – 2010. – Vol. 31. – P. 482 – 489.

  8. Egbuna O.I., Taylor J.G., Bushinsky D.A. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure // Clin Transplant. – 2007. – Vol. 21. – P. 558.

  9. Gilat H., Feinmesser R., Vinkler Y. Clinical and operative management of persistent hyperparathyroidism after renal transplantation: a single-center experience // Head Neck. – 2007. – Vol. 29. – P. 996–1001.

  10. Pitt S.C., Panneerselvan R., Chen H. et al. Secondary and Tertiary Hyperparathyroidism: The Utility of ioPTH Monitoring // World J Surg. – 2010. – Vol. 34. – P. 1343–1349.

  11. Huang M., Sprague S.M. Bone disease in kidney transplant patients // Semin Nephrol. – 2009. – Vol. 29. – P. 166–173.

  12. Mainra R., Elder G. Review article: Managing bone complications after kidney transplantation // Nephrology (Carlton). – 2009. – Vol. 14. – P. 437–442.

  13. Kievit A.J., Tinnemans J.G.M., Idu M.M. Outcome of Total Parathyroidectomy and Autotransplantation as Treatment of Secondary and Tertiary Hyperparathyroidism in Children and Adults // World J Surg. – 2010. – Vol. 34. – P. 993–1000.

  14. Schlosser K., Endres N., Celik I. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! // World J Surg. – 2007. – Vol. 31. – P. 1947–1953.

  15. Hsieh T.M., Sun C.K., Chen Y.T. et al. Total parathyroidectomy versus subtotal parathyroidectomy in the treatment of tertiary hyperparathyroidism // Am Surg. – 2012. – Vol. 78. – P. 600–606.

  16. Sadideen H.M., Taylor J.D., Goldsmith D.J. Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up // Int Urol Nephrol. – 2012. – Vol. 44. – P. 275–281.

  17. Schlosser K., Rothmund M., Maschuw K. Graf-dependent Renal Hyperparathyroidism Despite Successful Kidney Transplantation // World J Surg. – 2008. – Vol. 32. – P. 557–565.

  18. Rostaing L., Moreau-Gaudry X., Baron E. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism // Clin Nephrol. – 1997. – Vol. 47. – P. 248–255.

  19. Lee P.P., Schiffmann L., Offermann G. et al. Effects of parathyroidectomy on renal allograft survival // Kidney Blood Press Res. – 2004. – Vol. 27. – P. 191–196.

  20. Ветчинникова О.Н., Калинин А.П., Казанцева И.А. и др. Клинико-морфологические ассоциации при вторичном (почечном) гиперпаратиреозе // Материалы ХХ Российского симпозиума с международным участием «Современные аспекты хирургической эндокринологии». – Казань. – 2012. – С. 59–63.

  21. Ветчинникова О.Н., Ватазин А.В., Полякова Е.Ю. Цинакалцет в лечении вторичного (почечного) гиперпаратиреоза (результаты одноцентрового исследования) // Лечащий врач. – 2012. – Vol. 1. – C. 54–58.

  22. Block G.A., Marin K.J., de Francisco A.L. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis // N Engl J Med. – 2004. – Vol. 350. – P. 1516–1525.

  23. Meola M., Petrucci I., Barsotti G. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism // Nephrol Dial Transplant. – 2009. – Vol. 24. – P. 982–989.

  24. Peacock M., Bilezikian J.P., Klassen P.S. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism // J Clin Endocrinol Metab. – 2005. – Vol. 90. – P. 135–141.

  25. Serra A.L., Schwarz A.A., Wick F.H. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism // Nephrol Dial Transplant. – 2005. – Vol. 20. – P. 1315–1319.

  26. Serra A.L., Savoca R., Huber A.R. Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients // Nephrol Dial Transplant. – 2007. – Vol. 22. – P. 577–583.

  27. Kruse A.E., Eisenberger U., Frey F.J. et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism // Nephrol Dial Transplant. – 2005. – Vol. 20. – P. 1311–1314.

  28. Srinivas T.R., Schold J.D., Womer K.L. Improvement in hypercalcemia with cinacalcet after kidney transplantation // Clin J Am Soc Nephrol. – 2006. – Vol. 1. – P. 323–326.

  29. Leca N., Laftavi M., Gundroo A. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet // Am J Transplant. – 2006. – Vol. 10. – P. 2391–2395.

  30. Szwarc I., Argiles A., Garrigue V. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism // Transplantation. – 2006. – Vol. 82. – P. 675–680.

  31. Apostolou T., Kollia K., Damianou L. Hypercalcemia due to resistant hyperparathyroidism in renal transplant patients treated with the calcimimetic agent cinacalcet // Transplantation Proceedings. – 2006. – Vol. 38. – P. 3514–3516.

  32. El-Amm J.M., Doshi M.D., Singh A. Preliminary Experience With Cinacalcet Use in Persistent Secondary Hyperparathyroidism After Kidney Transplantation // Transplantation. – 2007. – Vol. 83 (5). – P. 546–549.

  33. Okada M., Tominaga Y., Izumi K. Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment // Ther Apher Dial. – 2011. – Vol. 15 (Suppl. 1). – P. 33–37.

  34. Borchhardt K.A., Heinzl H., Mayerwöger E. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation // Transplantation. – 2008. – Vol. 86. – P. 919–924.

  35. Bergua C., Torregrosa J.V., Fuster D. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism // Transplantation. – 2008. – Vol. 86. – P. 413–417.

  36. Borchhardt K.A., Diarra D., Sulzbacher I. Cinacalcet Decreases Bone Formation Rate in Hypercalcemic Hyperparathyroidism after Kidney Transplantation // Am J Nephrol. – 2010. – Vol. 31. – P. 482–489.

  37. Behets G., Spasovski G., Spiegel D.M. Bone Histomorphometry Before and After 12 Months of Treatment With Cinacalcet Among Dialysis Patients With Secondary Hyperparathyroidism (HPT) // Poster at ISN Nexus. – Copenhagen, Denmark. – September 20–23, 2012.

  38. Chattopadhyay N., Yano S., Tfelt-Hansen J. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts // Endocrinology. – 2004. – Vol. 145. – P. 3451–3455.

  39. Falck P., Vethe N.T., Аsberg A. Cinacalcet’s effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients // Nephrol Dial Transplant. – 2008. – Vol. 23. – P. 1048–1053.

  40. Kruse A.E., Eisenberger U., Frey F.J. et al. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism // Nephrol Dial Transplant. – 2007. – Vol. 22. – P. 2362–2365.


Об авторах / Для корреспонденции


Ветчинникова О.Н. – профессор кафедры трансплантологии, нефрологии и искусственных органов ФУВ ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», д.м.н.
E-mail: olg-vetchinnikova@yandex.ru;
Кантария Р.О. – нефролог хирургического отделения трансплантологии
и диализа ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», к.м.н.


Похожие статьи


Бионика Медиа